Analyst Finds 'Immense Discrepancy' in FDA Data on Bayer's Essure

Source: Reuters

Feb 19, 2016

A private analyst says the U.S. FDA may have greatly underestimated the number of fetal deaths among women who became pregnant after using Bayer's Essure contraceptive device.

While the FDA has cited five fetal deaths in women who became pregnant after using Essure, Madris Tomes, founder and CEO of Device Events, says the number is actually 303.

Tomes analyzed thousands of adverse events from the FDA's website, reading the detailed text of all complaints, and searching with a broader list of keywords than the FDA uses.

Approved in 2002, Essure was promoted as an alternative to tubal ligation. The FDA is expected to meet this month to make a decision that could involve restricting use of the device or additional clinical trials.

In 2013, famed consumer advocate Erin Brockovich launched a grassroots campaign against Essure, lobbying for the device to be taken off the market. Bayer maintains that the device is safe, claiming to have sold around 750,000 units.

Read the recent Reuters article



Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments